CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • The History and Future of Cancer Immunotherapy

    The path to achieving immunotherapy’s full potential.

    March 17, 2016| Arthur N. Brodsky, PhD
  • Rational Combinations 360° Conference Will Feature Two of CRI’s Leading Scientists

    The inaugural Rational Combinations 360° is a novel two-day forum on June 23-24, 2016, that will provide…

    March 11, 2016| Alexandra Mulvey
  • Oncogene Initiates Cancer Development through Immune Checkpoints

    CLIP investigator Dean W. Felsher, MD, PhD, published his findings in the journal Science.

    March 10, 2016| Alexandra Mulvey
  • We Will Remember, Always: A Shirt that Gives Back for Cancer Research

    Saddened by the actor Alan Rickman's death from pancreatic cancer, a T-shirt company raised $54,000 for CRI…

    March 8, 2016| CRI Staff
  • The March to May is Here

    The Cancer Research Institute (CRI) has set out to raise $400K before May 31 to power more…

    March 1, 2016| Hannah Belisle
  • CRI Meets with the Vice President’s Staff on Moonshot

    CRI and Vice President Biden’s Moonshot Initiative collaborate for the advancement of cancer immunotherapy research.

    February 26, 2016| Jill O'Donnell-Tormey, PhD
  • Laurie H. Glimcher, MD, to Head Dana-Farber Cancer Institute

    CRI Scientific Advisory Council member Laurie H. Glimcher, MD, will become the next president and CEO of…

    February 23, 2016| Alexandra Mulvey
  • A Cruise to Cure Cancer

    Because Janet, a travel agent, lost family and friends to cancer, she wanted to create a cruise…

    February 17, 2016| CRI Staff
  • Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers

    The era of powerful, personalized medicine draws near.

    February 17, 2016| Arthur N. Brodsky, PhD
Previous Page
1 … 73 74 75 76 77 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute